SP-MHCI-0760-3

Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

US$507.00

In stock

Description

About Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

The Human Hyaluronan mediated motility receptor (mutated sequence of EQAERLVKQ) Peptide (IEDB: 420535) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Hyaluronan mediated motility receptor Peptide, H-SLQEKVAKA-OH (Uniprot: O75330 aa: 393-401) from JPT is produced under strict quality control and quality management.

Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA - Specifications

  • Peptide sequence: H-SLQEKVAKA-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Immunogenic
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

References:
Read References with JPT’s Antigen Peptides
Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA has been described in:
Identification of Biological Relevant Minor Histocompatibility Antigens within the B-lymphocyte-Derived HLA-Ligandome Using a Reverse Immunology Approach., Clin Cancer Res, 2015 (PMID: 25589627)
Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients., Int J Cancer, 2002 (PMID: 12402309)

Documentation

Documentation for Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

Properties

Properties of Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Immunogenic
Layout: Freeze-dried in glass vial
Organism: Human
Protein Name: Hyaluronan mediated motility receptor
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Human Hyaluronan mediated motility receptor 393-401, SLQEKVAKA

Information Values
Sequence: H-SLQEKVAKA-OH
WT Sequence: EQAERLVKQ
Specifications: 9mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote